| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
681,430,000 |
| Market
Cap: |
8.70(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$11.18 - $27.7 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 10.5 |
| Insider 6 Months : 14.8 |
| Insider 3/6 Months : 25.7 |
|
| Guru Rank Number : 905 |
| Guru Rank Value : 1.1 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Avantor is a global manufacturer and distributor that provides products and services to customers in the biopharmaceutical, healthcare, education and government and advanced technologies and applied materials industries. Co.'s portfolio includes: Materials and consumables, such as lab products and supplies, formulated silicone materials, customized excipients, and customized single-use assemblies; equipment and instrumentation, such as filtration systems, virus inactivation systems, and incubators; and services and specialty procurement, such as onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
50,000 |
121,191 |
121,191 |
121,191 |
| Total Buy Value |
$628,000 |
$1,506,626 |
$1,506,626 |
$1,506,626 |
| Total People Bought |
1 |
4 |
4 |
4 |
| Total Buy Transactions |
2 |
7 |
7 |
7 |
| Total Shares Sold |
3,476 |
13,948 |
17,473 |
88,022 |
| Total Sell Value |
$39,592 |
$222,209 |
$310,546 |
$1,963,941 |
| Total People Sold |
1 |
2 |
2 |
4 |
| Total Sell Transactions |
1 |
5 |
6 |
14 |
| End Date |
2025-05-18 |
2025-02-14 |
2024-08-16 |
2023-08-17 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hankamer Brittany |
EVP, Chief HR Officer |
• – – |
2025-08-14 |
4 |
D |
$12.98 |
$2,349 |
D/D |
(181) |
171,563 |
|
- |
|
| Couturier Christophe |
EVP, AMEA |
• – – |
2025-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
65,217 |
211,271 |
|
- |
|
| Eck Steven W |
SVP & Chief Accounting Officer |
• – – |
2025-08-05 |
4 |
S |
$11.39 |
$39,592 |
D/D |
(3,476) |
55,068 |
|
-11% |
|
| Eck Steven W |
SVP & Chief Accounting Officer |
• – – |
2025-07-31 |
4 |
D |
$13.44 |
$18,614 |
D/D |
(1,385) |
58,544 |
|
- |
|
| Sokenu Claudius |
EVP, Chief Legal & Compliance |
• – – |
2025-07-24 |
4 |
D |
$14.01 |
$43,753 |
D/D |
(3,123) |
177,106 |
|
- |
|
| Walker Corey |
President Laboratory Solutions |
• – – |
2025-06-21 |
4 |
D |
$13.57 |
$37,046 |
D/D |
(2,730) |
231,271 |
|
- |
|
| Summe Gregory L |
Director |
– • – |
2025-05-23 |
4 |
B |
$12.50 |
$375,000 |
I/I |
30,000 |
100,000 |
2.1 |
2% |
|
| Summe Gregory L |
Director |
– • – |
2025-05-22 |
4 |
B |
$12.65 |
$253,000 |
I/I |
20,000 |
70,000 |
2.1 |
1% |
|
| Stubblefield Michael |
President & CEO |
• • – |
2025-05-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
76,000 |
545,500 |
|
- |
|
| Stubblefield Michael |
President & CEO |
• • – |
2025-05-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
76,000 |
1,219,013 |
|
- |
|
| Eck Steven W |
SVP & Chief Accounting Officer |
• – – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
20,358 |
59,929 |
|
- |
|
| Sokenu Claudius |
EVP, Chief Legal & Compliance |
• – – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
122,149 |
180,229 |
|
- |
|
| Jones R. Brent |
EVP, Chief Financial Officer |
• – – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
162,866 |
269,676 |
|
- |
|
| Walker Corey |
President Laboratory Solutions |
• – – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
162,866 |
234,001 |
|
- |
|
| Hankamer Brittany |
EVP, Chief HR Officer |
• – – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
122,149 |
171,744 |
|
- |
|
| Gourdier Benoit |
EVP, Bioscience Production |
• – – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
162,866 |
236,948 |
|
- |
|
| Couturier Christophe |
EVP, AMEA |
• – – |
2025-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
61,074 |
144,914 |
|
- |
|
| Massaro Joseph R |
Director |
– • – |
2025-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
17,100 |
52,138 |
|
- |
|
| Murthy Mala |
Director |
– • – |
2025-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
17,100 |
44,209 |
|
- |
|
| Andres Juan |
Director |
– • – |
2025-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
17,100 |
65,480 |
|
- |
|
| Carethers John |
Director |
– • – |
2025-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
17,100 |
45,858 |
|
- |
|
| Kang Lan |
Director |
– • – |
2025-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
17,100 |
52,315 |
|
- |
|
| Makin Louise |
Director |
– • – |
2025-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
17,100 |
21,870 |
|
- |
|
| Severino Michael |
Director |
– • – |
2025-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
17,100 |
60,551 |
|
- |
|
| Summe Gregory L |
Director |
– • – |
2025-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
17,100 |
58,111 |
|
- |
|
612 Records found
|
|
Page 1 of 25 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.17 (1.31%) 
